[APLS] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -38.71%
YoY- -132.67%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue -142 0 0 0 12 0 0 -
PBT -113,217 -69,825 -71,090 -50,574 -36,459 -35,972 -33,334 125.44%
Tax 3,981 540 388 340 2,383 -281 -33,669 -
NP -113,217 -69,825 -71,090 -50,574 -36,459 -35,972 -33,334 125.44%
Tax Rate - - - - - - - -
Total Cost 113,075 69,825 71,090 50,574 36,471 35,972 33,334 125.26%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 79,646.45 0.00 0.00 0.00 -315,885.24 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -1.54 -1.10 -1.12 -0.87 -0.65 -0.64 -0.61 85.09%
EPS Diluted -1.54 -1.10 -1.12 -0.87 -0.63 -0.64 -0.61 85.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.